Aberrant DNA methylation associated with bipolar disorder identified from discordant monozygotic twins

G. Kuratomi, K. Iwamoto, M. Bundo, I. Kusumi, N. Kato, Nakao Iwata, N. Ozaki, T. Kato

Research output: Contribution to journalArticle

134 Citations (Scopus)

Abstract

To search DNA methylation difference between monozygotic twins discordant for bipolar disorder, we applied a comprehensive genome scan method, methylation-sensitive representational difference analysis (MS-RDA) to lymphoblastoid cells derived from the twins. MS-RDA isolated 10 DNA fragments derived from 5′ region of known genes/ESTs. Among these 10 regions, four regions showed DNA methylation differences between bipolar twin and control co-twin confirmed by bisulfite sequencing. We performed a case-control study of DNA methylation status of these four regions by pyrosequencing. Two regions, upstream regions of spermine synthase (SMS) and peptidylprolyl isomerase E-like (PPIEL) (CN265253), showed aberrant DNA methylation status in bipolar disorder. SMS, a gene on X chromosome, showed significantly higher DNA methylation level in female patients with bipolar disorder compared with control females. However, there was no difference of mRNA expression. In PPIEL, DNA methylation level was significantly lower in patients with bipolar II disorder than in controls. The expression level of PPIEL was significantly higher in bipolar II disorder than in controls. We found strong inverse correlation between gene expression and DNA methylation levels of PPIEL. These results suggest that altered DNA methylation statuses of PPIEL might have some significance in pathophysiology of bipolar disorder.

Original languageEnglish
Pages (from-to)429-441
Number of pages13
JournalMolecular Psychiatry
Volume13
Issue number4
DOIs
Publication statusPublished - 01-04-2008

Fingerprint

Monozygotic Twins
DNA Methylation
Bipolar Disorder
Peptidylprolyl Isomerase
Spermine Synthase
Methylation
X-Linked Genes
Expressed Sequence Tags
Case-Control Studies
Genome
Gene Expression
Messenger RNA
DNA

All Science Journal Classification (ASJC) codes

  • Molecular Biology
  • Psychiatry and Mental health
  • Cellular and Molecular Neuroscience

Cite this

Kuratomi, G. ; Iwamoto, K. ; Bundo, M. ; Kusumi, I. ; Kato, N. ; Iwata, Nakao ; Ozaki, N. ; Kato, T. / Aberrant DNA methylation associated with bipolar disorder identified from discordant monozygotic twins. In: Molecular Psychiatry. 2008 ; Vol. 13, No. 4. pp. 429-441.
@article{c0cedb8574e140a29fad31681afc0192,
title = "Aberrant DNA methylation associated with bipolar disorder identified from discordant monozygotic twins",
abstract = "To search DNA methylation difference between monozygotic twins discordant for bipolar disorder, we applied a comprehensive genome scan method, methylation-sensitive representational difference analysis (MS-RDA) to lymphoblastoid cells derived from the twins. MS-RDA isolated 10 DNA fragments derived from 5′ region of known genes/ESTs. Among these 10 regions, four regions showed DNA methylation differences between bipolar twin and control co-twin confirmed by bisulfite sequencing. We performed a case-control study of DNA methylation status of these four regions by pyrosequencing. Two regions, upstream regions of spermine synthase (SMS) and peptidylprolyl isomerase E-like (PPIEL) (CN265253), showed aberrant DNA methylation status in bipolar disorder. SMS, a gene on X chromosome, showed significantly higher DNA methylation level in female patients with bipolar disorder compared with control females. However, there was no difference of mRNA expression. In PPIEL, DNA methylation level was significantly lower in patients with bipolar II disorder than in controls. The expression level of PPIEL was significantly higher in bipolar II disorder than in controls. We found strong inverse correlation between gene expression and DNA methylation levels of PPIEL. These results suggest that altered DNA methylation statuses of PPIEL might have some significance in pathophysiology of bipolar disorder.",
author = "G. Kuratomi and K. Iwamoto and M. Bundo and I. Kusumi and N. Kato and Nakao Iwata and N. Ozaki and T. Kato",
year = "2008",
month = "4",
day = "1",
doi = "10.1038/sj.mp.4002001",
language = "English",
volume = "13",
pages = "429--441",
journal = "Molecular Psychiatry",
issn = "1359-4184",
publisher = "Nature Publishing Group",
number = "4",

}

Kuratomi, G, Iwamoto, K, Bundo, M, Kusumi, I, Kato, N, Iwata, N, Ozaki, N & Kato, T 2008, 'Aberrant DNA methylation associated with bipolar disorder identified from discordant monozygotic twins', Molecular Psychiatry, vol. 13, no. 4, pp. 429-441. https://doi.org/10.1038/sj.mp.4002001

Aberrant DNA methylation associated with bipolar disorder identified from discordant monozygotic twins. / Kuratomi, G.; Iwamoto, K.; Bundo, M.; Kusumi, I.; Kato, N.; Iwata, Nakao; Ozaki, N.; Kato, T.

In: Molecular Psychiatry, Vol. 13, No. 4, 01.04.2008, p. 429-441.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Aberrant DNA methylation associated with bipolar disorder identified from discordant monozygotic twins

AU - Kuratomi, G.

AU - Iwamoto, K.

AU - Bundo, M.

AU - Kusumi, I.

AU - Kato, N.

AU - Iwata, Nakao

AU - Ozaki, N.

AU - Kato, T.

PY - 2008/4/1

Y1 - 2008/4/1

N2 - To search DNA methylation difference between monozygotic twins discordant for bipolar disorder, we applied a comprehensive genome scan method, methylation-sensitive representational difference analysis (MS-RDA) to lymphoblastoid cells derived from the twins. MS-RDA isolated 10 DNA fragments derived from 5′ region of known genes/ESTs. Among these 10 regions, four regions showed DNA methylation differences between bipolar twin and control co-twin confirmed by bisulfite sequencing. We performed a case-control study of DNA methylation status of these four regions by pyrosequencing. Two regions, upstream regions of spermine synthase (SMS) and peptidylprolyl isomerase E-like (PPIEL) (CN265253), showed aberrant DNA methylation status in bipolar disorder. SMS, a gene on X chromosome, showed significantly higher DNA methylation level in female patients with bipolar disorder compared with control females. However, there was no difference of mRNA expression. In PPIEL, DNA methylation level was significantly lower in patients with bipolar II disorder than in controls. The expression level of PPIEL was significantly higher in bipolar II disorder than in controls. We found strong inverse correlation between gene expression and DNA methylation levels of PPIEL. These results suggest that altered DNA methylation statuses of PPIEL might have some significance in pathophysiology of bipolar disorder.

AB - To search DNA methylation difference between monozygotic twins discordant for bipolar disorder, we applied a comprehensive genome scan method, methylation-sensitive representational difference analysis (MS-RDA) to lymphoblastoid cells derived from the twins. MS-RDA isolated 10 DNA fragments derived from 5′ region of known genes/ESTs. Among these 10 regions, four regions showed DNA methylation differences between bipolar twin and control co-twin confirmed by bisulfite sequencing. We performed a case-control study of DNA methylation status of these four regions by pyrosequencing. Two regions, upstream regions of spermine synthase (SMS) and peptidylprolyl isomerase E-like (PPIEL) (CN265253), showed aberrant DNA methylation status in bipolar disorder. SMS, a gene on X chromosome, showed significantly higher DNA methylation level in female patients with bipolar disorder compared with control females. However, there was no difference of mRNA expression. In PPIEL, DNA methylation level was significantly lower in patients with bipolar II disorder than in controls. The expression level of PPIEL was significantly higher in bipolar II disorder than in controls. We found strong inverse correlation between gene expression and DNA methylation levels of PPIEL. These results suggest that altered DNA methylation statuses of PPIEL might have some significance in pathophysiology of bipolar disorder.

UR - http://www.scopus.com/inward/record.url?scp=40849116456&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=40849116456&partnerID=8YFLogxK

U2 - 10.1038/sj.mp.4002001

DO - 10.1038/sj.mp.4002001

M3 - Article

C2 - 17471289

AN - SCOPUS:40849116456

VL - 13

SP - 429

EP - 441

JO - Molecular Psychiatry

JF - Molecular Psychiatry

SN - 1359-4184

IS - 4

ER -